Dendritic cells prevent rather than promote immunity conferred by a helicobacter vaccine using a mycobacterial adjuvant

Gastroenterology

Volumn 141, Issue 1, 2011, Pages

  Hitzler, Iris ^a   Oertli, Mathias ^a   Becher, Burkhard ^a   Agger, Else Marie ^b   Müller, Anne ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

Bacteria; Gastric Adenocarcinoma; Gastric Cancer; Ulcer

Indexed keywords

BACTERIAL VACCINE; CAF 01; CHOLERA TOXIN; HELICOBACTER VACCINE; IMMUNOLOGICAL ADJUVANT; MYCOBACTERIAL ADJUVANT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BACTERIAL CELL WALL; BACTERIAL IMMUNITY; CD4+ T LYMPHOCYTE; CELL ASSAY; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HELPER CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INFECTION CONTROL; LYMPHATIC DRAINAGE; MEMORY T LYMPHOCYTE; MESENTERY LYMPH NODE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH; STOMACH MUCOSA; T CELL DEPLETION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; WHOLE CELL;

EID: 79959981052     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.04.009     Document Type: Article

References (40)

1. B.J. Marshall, and H.M. Windsor The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology, epidemiology, screening, clinical presentation, treatment, and prevention Med Clin North Am 89 2005 313 344 (Pubitemid 40126820)
2. F. Mégraud H pylori antibiotic resistance: prevalence, importance, and advances in testing Gut 53 2004 1374 1384 (Pubitemid 39120130)
3. A. Zullo, C. Hassan, and A. Eramo Gastric cancer following Helicobacter pylori eradication in duodenal ulcer patients Digest Liver Dis 38 2006 528 529 (Pubitemid 44356226)
4. T. Rokkas, D. Pistiolas, and P. Sechopoulos The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis Helicobacter 12 Suppl 2 2007 32 38 (Pubitemid 350076224)
5. E.S. DeLyria, R.W. Redline, and T.G. Blanchard Vaccination of mice against H pylori induces a strong Th-17 response and immunity that is neutrophil dependent Gastroenterology 136 2009 247 256
6. A. Mueller, J. O'Rourke, and P. Chu Protective immunity against Helicobacter is characterized by a unique transcriptional signature Proc Natl Acad Sci 100 2003 12289 12294 (Pubitemid 37271553)
7. + T cell-mediated IFN-gamma response to Helicobacter infection is essential for clearance and determines gastric cancer risk J Immunol 182 2009 7085 7101
8. M. Chen, A. Lee, and S. Hazell Immunisation against gastric Helicobacter infection in a mouse/Helicobacter felis model Lancet 339 1992 1120 1121
9. S. Banerjee, A. Medina-Fatimi, and R. Nichols Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers Gut 51 2002 634 640 (Pubitemid 35216848)
10. S. Sougioultzis, C.K. Lee, and M. Alsahli Safety and efficacy of E. coli enterotoxin adjuvant for urease-based rectal immunization against Helicobacter pylori Vaccine 21 2002 194 201 (Pubitemid 35346814)
11. K.L. Kotloff, M.B. Sztein, and S.S. Wasserman Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection Infect Immun 69 2001 3581 3590 (Pubitemid 32493271)
12. M.D. DiPetrillo, T. Tibbetts, and H. Kleanthous Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers Vaccine 18 1999 449 459 (Pubitemid 29462601)
13. D. Bumann, W.G. Metzger, and E. Mansouri Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers Vaccine 20 2001 845 852 (Pubitemid 34015824)
14. T. Aebischer, D. Bumann, and H.J. Epple Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines Gut 57 2008 1065 1072
15. A.A. Akhiani, J. Pappo, and Z. Kabok Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells J Immunol 169 2002 6977 6984 (Pubitemid 36899285)
16. A.A. Akhiani, K. Schon, and N. Lycke Vaccine-induced immunity against Helicobacter pylori infection is impaired in IL-18-deficient mice J Immunol 173 2004 3348 3356 (Pubitemid 39142044)
17. T.H. Ermak, P.J. Giannasca, and R. Nichols Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses J Exp Med 188 1998 2277 2288 (Pubitemid 29028500)
18. D. Velin, L. Favre, and E. Bernasconi Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model Gastroenterology 136 2009 2237 2246.e1
19. G. Rossi, P. Ruggiero, and S. Peppoloni Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: safety, immunogenicity, and efficacy Infect Immun 72 2004 3252 3259 (Pubitemid 38697746)
20. J.M. Gottwein, T.G. Blanchard, and O.S. Targoni Protective anti-Helicobacter immunity is induced with aluminum hydroxide or complete Freund's adjuvant by systemic immunization J Infect Dis 184 2001 308 314 (Pubitemid 32662177)
21. J.C. Eisenberg, S.J. Czinn, and C.A. Garhart Protective efficacy of antiHelicobacter pylori immunity following systemic immunization of neonatal mice Infect Immun 71 2003 1820 1827 (Pubitemid 36368711)
22. P. Malfertheiner, V. Schultze, and B. Rosenkranz Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study Gastroenterology 135 2008 787 795
23. K. Werninghaus, A. Babiak, and O. Gross Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation J Exp Med 206 2009 89 97
24. K.S. Korsholm, E.M. Agger, and C. Foged The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes Immunology 121 2007 216 226 (Pubitemid 46663090)
25. A.T. Kamath, A.-F. Rochat, and D. Christensen A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells PLoS ONE 4 2009 e5771
26. J. Davidsen, I. Rosenkrands, and D. Christensen Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′-dibehenate)a novel adjuvant inducing both strong CMI and antibody responses Biochim Biophys Acta Biomembr 1718 2005 22 31 (Pubitemid 41698893)
27. E.M. Agger, I. Rosenkrands, and J. Hansen Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements PLoS ONE 3 2008 e3116
28. H. Gu, Y.R. Zou, and K. Rajewsky Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting Cell 73 1993 1155 1164 (Pubitemid 23180489)
29. K. Lahl, C. Loddenkemper, and C. Drouin Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease J Exp Med 204 2007 57 63 (Pubitemid 46148756)
30. A. Lee, J. O'Rourke, and M.C.D. Ungria A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain Gastroenterology 112 1997 1386 1397 (Pubitemid 27157555)
31. T.G. Blanchard, S.J. Czinn, and R.W. Redline Antibody-independent protective mucosal immunity to gastric Helicobacter infection in mice Cellular Immunology 191 1999 74 80 (Pubitemid 29054969)
32. C.A. Garhart, J.G. Nedrud, and F.P. Heinzel Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4 Infect Immun 71 2003 3628 3633 (Pubitemid 36637595)
33. P. Sutton, J. Wilson, and T. Kosaka Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies Immunol Cell Biol 78 2000 28 30 (Pubitemid 30090986)
34. D. Velin, D. Bachmann, and H. Bouzourene Mast cells are critical mediators of vaccine-induced Helicobacter clearance in the mouse model Gastroenterology 129 2005 142 155 (Pubitemid 41002051)
35. I.M. Toller, I. Hitzler, and A. Sayi Prostaglandin E2 prevents Helicobacter-induced gastric preneoplasia and facilitates persistent infection in a mouse model Gastroenterology 138 2010 1455 1467 1467.e1-4
36. A. Mueller, A. Sayi, and I. Hitzler Protective and pathogenic functions of T cells are inseparable during the Helicobacter-host interaction Discov Med 8 2009 68 73
37. I. Arnold, J.Y. Lee, and M.R. Amieva Tolerance rather than immunity protects from Helicobacter pyloriinduced gastric preneoplasia Gastroenterology 140 2011 199 209
38. J. Pappo, D. Torrey, and L. Castriotta Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions Infect Immun 67 1999 337 341 (Pubitemid 29021667)
39. J.M. Taylor, M.E. Ziman, and D.R. Canfield Effects of a Th1- versus a Th2-biased immune response in protection against Helicobacter pylori challenge in mice Microb Pathog 44 2007 20 27 (Pubitemid 350236689)
40. J.Y. Kao, M. Zhang, and M.J. Miller Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice Gastroenterology 138 2010 1046 1054